Skip to content

Long term follow-up of the Tendril STS and Isoflex leads in conjunction with the Assurity MRI* and Endurity MRI* Pacemakers within the 3T MRI Environment

Long term follow-up of the Tendril STS and Isoflex leads in conjunction with the Assurity MRI* and Endurity MRI* Pacemakers within the 3T MRI Environment - Brady 3T MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49741
Enrollment
20
Registered
2019-07-22
Start date
2019-10-04
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

veiligheidsonderzoek in het kader van PMCF van MRI compatibele pacemaker in combinatie met 3T MRI cardiac rythme disorders

Interventions

None listed

Sponsors

Abbott Medical Nederland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Eligible subjects will meet all of the following: * Are implanted with a St. Jude Medical Assurity MRI or Endurity MRI pacemaker and Tendril STS 2088 or Isoflex 1944/1948 lead * Capture threshold is stable and

Exclusion criteria

Exclusion criteria: Subjects will be excluded if they meet any of the following: * Are

Design outcomes

Primary

MeasureTime frame
Primary Endpoint#1: Proportion of subjects with a capture threshold increase of * 0.5V at the permanently programmed pulse width from pre- MRI scan to one-month post MRI scan.

Secondary

MeasureTime frame
Primary Endpoint #2: Proportion of subjects with a sensing amplitude decrease of * 50% from pre- MRI scan to one-month post MRI scan.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)